The prognostic significance of LAT1 in MM was investigated by immunohistochemistry to monitor the expression of LAT1 and its functional subunit, 4Fc heavy chain (CD98), on tumor cells in 100 newly diagnosed MM (NDMM) patients (84). Here, SLC7A5 is linked to Miyoshi myopathy.